The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.1002/med.21976
|View full text |Cite
|
Sign up to set email alerts
|

New drug approvals for 2022: Synthesis and clinical applications

Abstract: The U.S. Food and Drug Administration has approved a total of 37 new drugs in 2022, which are composed of 20 chemical entities and 17 biologics. In particular, 20 chemical entities, including 17 small molecule drugs, 1 radiotherapy, and 2 diagnostic agents, provide privileged scaffolds, breakthrough clinical benefits, and a new mechanism of action for the discovery of more potent clinical candidates. The structure‐based drug development with clear targets and fragment‐based drug development with privileged sca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(3 citation statements)
references
References 159 publications
0
2
0
1
Order By: Relevance
“…This is of great value for the development of new drugs and the improvement of existing drug regimens. Safety and toxicological assessment: Understanding the safety and possible side effects of P. ternata is essential to ensuring its safety in clinical applications (Yuan et al, 2023). The study of the toxicological properties of P. ternata can help guide its rational use in medical practice.…”
Section: Significance Of Studying Pinellia Ternatamentioning
confidence: 99%
“…This is of great value for the development of new drugs and the improvement of existing drug regimens. Safety and toxicological assessment: Understanding the safety and possible side effects of P. ternata is essential to ensuring its safety in clinical applications (Yuan et al, 2023). The study of the toxicological properties of P. ternata can help guide its rational use in medical practice.…”
Section: Significance Of Studying Pinellia Ternatamentioning
confidence: 99%
“…[2] The discovery of new drugs relies heavily on the structural diversity and innovation provided by small molecules. [3] Therefore, merging spirocyclic lactam and aza-spiropyrazolone architectures to generate structurally intriguing spiropyrazolone-lactam frameworks could provide a potent strategy for identifying promising drug candidates. [2c,4d] However, research focused on constructing such valuable nitrogen-enriched spirocyclic structures has been minimal compared to the more extensively studied spirocyclic lactams and aza-spiropyrazolones.…”
Section: Introductionmentioning
confidence: 99%
“…Как известно все новые ЛС можно условно поделить на: содержащие малые молекулы или препараты, созданные на основании биологического подхода. При этом широкое распространение биотехнологии до недавнего времени ограничивалось уровнем развития технологий и стоимостью, но при этом практически все участники сходились во мнении, что биотехнология рано или поздно предоставит больше возможностей для фармацевтической разработки, чем медицинская химия [16][17][18]. В то же время разработка лекарств на основе химического синтеза и медицинская химия как наука претерпели и продолжают претерпевать ряд существенных изменений.…”
unclassified